Literature DB >> 25548319

Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium.

Lorenzo Villa1, Diana Sun2, Kris Denhaerynck3, Stefaan Vancayzeele4, Heidi Brié4, Christine Hermans4, Ann Aerts4, Michael Levengood5, Karen MacDonald6, Ivo Abraham7.   

Abstract

BACKGROUND: Patient adherence is often not monitored because existing methods of evaluating adherence are either burdensome or do not accurately predict treatment outcomes. AIM: To examine whether two simple, single-item physician-administered measures of patient adherence to antihypertensive medication are predictive of blood pressure outcomes. DESIGN AND
SETTING: Retrospective database analysis of patients with hypertension treated in Belgian primary care.
METHOD: Using pooled data from five observational studies, a sample was identified of 9725 patients who were assessed using two single-item physician-administered measures of adherence to antihypertensive medication: the first item of the Basel Assessment of Adherence Scale (BAAS) and the Visual Analogue Scale (VAS). These two assessment tools were administered by GPs during regular appointments with patients. Systolic blood pressure (SBP), diastolic blood pressure (DBP), and combined SBP/DBP were measured at baseline and at 90 days.
RESULTS: BAAS-identified adherent patients achieved lower mean SBP and DBP compared with non-adherent patients at 90 days (P<0.001), and had odds ratios of achieving blood pressure control of 0.66 (95% confidence intervals (CI) = 0.61 to 0.73, P<0.001) for SBP, 0.69 (95% CI = 0.62 to 0.76, P<0.001) for DBP, and 0.65 (95% CI = 0.59 to 0.72, P<0.001) for combined SBP/DBP. For VAS-identified adherent patients, the odds ratios of achieving blood pressure control were 0.93 (95% CI = 0.86 to 1.00, P<0.001) for SBP, 0.79 (95% CI = 0.73 to 0.85, P<0.001) for DBP, and 0.91 (95% CI = 0.84 to 0.99, P<0.001) for combined SBP/DBP.
CONCLUSIONS: The first item of the BAAS and the VAS are independent predictors of blood pressure control. These methods can be integrated seamlessly into routine clinical practice by allowing GPs to quickly evaluate a patient's adherence and tailor treatment recommendations accordingly. © British Journal of General Practice 2015.

Entities:  

Keywords:  hypertension; medication adherence; patient adherence; primary health care

Mesh:

Substances:

Year:  2015        PMID: 25548319      PMCID: PMC4276010          DOI: 10.3399/bjgp15X683101

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  25 in total

Review 1.  The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review.

Authors:  Fabienne Dobbels; Lut Berben; Sabina De Geest; Gerda Drent; Annette Lennerling; Clare Whittaker; Christiane Kugler
Journal:  Transplantation       Date:  2010-07-27       Impact factor: 4.939

2.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

3.  Medication adherence: WHO cares?

Authors:  Marie T Brown; Jennifer K Bussell
Journal:  Mayo Clin Proc       Date:  2011-03-09       Impact factor: 7.616

4.  Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study.

Authors:  Robert Lins; Nicolas Coen; Ann Aerts; Karen Macdonald; Heidi Brié; Christine Hermans; Yu-Ming Shen; Christopher Lee; Stefaan Vancayzeele; Natalie Mecum; Ivo Abraham
Journal:  Arch Cardiovasc Dis       Date:  2011-02-22       Impact factor: 2.340

5.  Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study).

Authors:  Robert Lins; Ann Aerts; Nicolas Coen; Christine Hermans; Karen MacDonald; Heidi Brié; Christopher Lee; Yu-Ming Shen; Stefaan Vancayzeele; Natalie Mecum; Ivo Abraham
Journal:  Ann Pharmacother       Date:  2011-06-10       Impact factor: 3.154

Review 6.  Selection of a validated scale for measuring medication adherence.

Authors:  Stacey M Lavsa; Ashley Holzworth; Nicole T Ansani
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Jan-Feb

7.  A simple single-item rating scale to measure medication adherence: further evidence for convergent validity.

Authors:  Seth C Kalichman; Christina M Amaral; Connie Swetzes; Michelle Jones; Rene Macy; Moira O Kalichman; Chauncey Cherry
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2009 Nov-Dec

Review 8.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

Review 9.  Epidemiology of resistant hypertension.

Authors:  Pantelis A Sarafidis
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-28       Impact factor: 3.738

Review 10.  Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.

Authors:  Ivo Abraham; Karen MacDonald; Christine Hermans; Ann Aerts; Christopher Lee; Heidi Brié; Stefaan Vancayzeele
Journal:  Vasc Health Risk Manag       Date:  2011-03-31
View more
  5 in total

1.  Association between adherence, treatment satisfaction and illness perception in hypertensive patients.

Authors:  S Saarti; A Hajj; L Karam; H Jabbour; A Sarkis; N El Osta; L Rabbaa Khabbaz
Journal:  J Hum Hypertens       Date:  2015-08-27       Impact factor: 3.012

2.  Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study.

Authors:  Mark J Butler; Rikki M Tanner; Paul Muntner; Daichi Shimbo; Adam P Bress; Amanda J Shallcross; Mario Sims; Gbenga Ogedegbe; Tanya M Spruill
Journal:  J Am Soc Hypertens       Date:  2017-07-06

3.  A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults.

Authors:  R Bou Serhal; P Salameh; N Wakim; C Issa; B Kassem; L Abou Jaoude; N Saleh
Journal:  Int J Hypertens       Date:  2018-05-20       Impact factor: 2.420

4.  Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Hypertensive Patients with and without Diabetes: Pooled Analysis of Six Observational Valsartan Studies with 15,282 Evaluable Patients.

Authors:  Noha Ashy; Thanh-Nga Nguyen; Kris Denhaerynck; Mahdi Gharaibeh; Abdulaziz Alhossan; Stefaan Vancayzeele; Heidi Brié; Ann Aerts; Karen MacDonald; Ivo Abraham
Journal:  Int J Chronic Dis       Date:  2017-09-25

5.  Evaluating the Role of Clinical Pharmacists in Providing Pharmaceutical Care to Improve Adherence in Hypertensive Patients at a Rural Hospital in Southern Chile: A Pilot Study.

Authors:  Yolanda Espinosa; Pia M Córdova; Pola B Fernández; Felipe E Morales; Lorenzo A Villa
Journal:  J Res Pharm Pract       Date:  2019-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.